JP2023540444A5 - - Google Patents

Info

Publication number
JP2023540444A5
JP2023540444A5 JP2023507798A JP2023507798A JP2023540444A5 JP 2023540444 A5 JP2023540444 A5 JP 2023540444A5 JP 2023507798 A JP2023507798 A JP 2023507798A JP 2023507798 A JP2023507798 A JP 2023507798A JP 2023540444 A5 JP2023540444 A5 JP 2023540444A5
Authority
JP
Japan
Prior art keywords
antibody
seq
cdr
antigen
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023507798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540444A (ja
Filing date
Publication date
Priority claimed from GBGB2012331.1A external-priority patent/GB202012331D0/en
Application filed filed Critical
Publication of JP2023540444A publication Critical patent/JP2023540444A/ja
Publication of JP2023540444A5 publication Critical patent/JP2023540444A5/ja
Pending legal-status Critical Current

Links

JP2023507798A 2020-08-07 2021-08-06 治療用抗体 Pending JP2023540444A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2012331.1 2020-08-07
GBGB2012331.1A GB202012331D0 (en) 2020-08-07 2020-08-07 Therapeutic antibodies
PCT/GB2021/052043 WO2022029447A1 (en) 2020-08-07 2021-08-06 Therapeutic antibodies

Publications (2)

Publication Number Publication Date
JP2023540444A JP2023540444A (ja) 2023-09-25
JP2023540444A5 true JP2023540444A5 (cg-RX-API-DMAC7.html) 2026-02-02

Family

ID=72520053

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507798A Pending JP2023540444A (ja) 2020-08-07 2021-08-06 治療用抗体

Country Status (8)

Country Link
US (1) US20230272097A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192867A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023540444A (cg-RX-API-DMAC7.html)
CN (1) CN116249710A (cg-RX-API-DMAC7.html)
AU (1) AU2021319941A1 (cg-RX-API-DMAC7.html)
CA (1) CA3186391A1 (cg-RX-API-DMAC7.html)
GB (1) GB202012331D0 (cg-RX-API-DMAC7.html)
WO (1) WO2022029447A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017189805A1 (en) 2016-04-27 2017-11-02 Abbvie Inc. Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies
US10093731B2 (en) 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
JP7671275B2 (ja) 2019-08-29 2025-05-01 エランコ・ユーエス・インコーポレイテッド 動物用の抗il31抗体
US20220332837A1 (en) * 2021-04-08 2022-10-20 Colorado State University Research Foundation Methods and compositions for ox40 activation in treatment of canine cancer
WO2023152486A1 (en) * 2022-02-09 2023-08-17 Petmedix Ltd Therapeutic antibodies
GB202217978D0 (en) * 2022-11-30 2023-01-11 Petmedix Ltd Rodents expressing a common light chain
KR20250137204A (ko) 2022-12-27 2025-09-17 인베티엑스 인코포레이티드 신생아 fc 수용체(fcrn)에 대한 결합이 변경된 폴리펩타이드 및 사용 방법
CN121002059A (zh) 2023-01-20 2025-11-21 因外泰克斯公司 用于伴侣动物的双特异性结合剂
US20250257142A1 (en) * 2024-02-13 2025-08-14 Invetx, Inc. Anti-il-31ra antibodies and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
CA2560889A1 (en) * 2004-03-23 2005-10-13 Sanjay D. Khare Monoclonal antibodies specific for human ox40l (cd 134l)
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
US7812133B2 (en) * 2005-12-16 2010-10-12 Genentech, Inc Anti-OX40L antibodies and methods using same
KR102119840B1 (ko) 2011-07-11 2020-06-09 아이크노스 사이언스 에스. 아. Ox40에 결합하는 항체 및 이들의 용도
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
EA032389B1 (ru) * 2012-02-14 2019-05-31 Мериал, Инк. Рекомбинантные поксвирусные векторы, кодирующие и экспрессирующие гликопротеин g вируса бешенства и полипептид oxl, и вакцины, созданные на их основе, используемые в способе вакцинации животных против бешенства
GB201316644D0 (en) 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening
US10196435B2 (en) 2013-11-18 2019-02-05 University Of Southern California OX40L fusion protein for the immunotherapy of tumors of veterinary animals
PL3265123T3 (pl) 2015-03-03 2023-03-13 Kymab Limited Przeciwciała, zastosowania i sposoby
GB2561352B (en) 2017-04-10 2023-01-18 Genome Res Ltd Animal models and therapeutic molecules
JP7449234B2 (ja) 2018-03-16 2024-03-13 ゾエティス・サービシーズ・エルエルシー 獣医学使用のためのインターロイキン31モノクローナル抗体
GB2578867A (en) 2018-10-09 2020-06-03 Genome Res Ltd Animal models and therapeutic molecules

Similar Documents

Publication Publication Date Title
US20250122301A1 (en) Cd25 antibodies
RU2474588C2 (ru) Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
Willems et al. Rituximab therapy for childhood-onset systemic lupus erythematosus
US10479830B2 (en) Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines
HUE034282T2 (en) A monoclonal antibody to dog interleukin-31
RU2014121043A (ru) Биспецифические иммуносвязывающие средства, направленные против tnf и il-17
CN109384844B (zh) 一种抗金黄色葡萄球菌α溶血素单克隆抗体及应用
JP2017513813A5 (cg-RX-API-DMAC7.html)
JP2023540444A (ja) 治療用抗体
WO2009140348A4 (en) Anti-il-6/il-6r antibodies and methods of use thereof
JP2017525655A5 (cg-RX-API-DMAC7.html)
WO2022117079A1 (zh) 结合胸腺基质淋巴细胞生成素的抗体及其应用
JP2022527646A5 (cg-RX-API-DMAC7.html)
WO2005114218B1 (en) Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
Hu et al. Potential therapeutic strategies in chronic inflammatory demyelinating polyradiculoneuropathy
JP2025506488A5 (cg-RX-API-DMAC7.html)
RU2024121576A (ru) Терапевтические антитела
US20240360210A1 (en) Use of an il-18 antagonist for treating and/or prevention of atopic dermatitis or a related condition
KR20230154239A (ko) 항체-매개 이식 거부의 치료에 사용하기 위한 항-cd38 항체
CN118715244A (zh) 治疗性抗体
JP2025506488A (ja) 治療抗体
CN104391114B (zh) Elisa方法定量测定人血清中重组人鼠嵌合抗cd20单克隆抗体浓度
RU2795411C2 (ru) Моноклональные антитела к интерлейкину-31 для ветеринарного применения
HK40063825A (en) Cd25 antibodies
NZ773527B2 (en) Antibodies, uses & methods